Trial Profile
A multicentre randomised, double-blind, parallel-group study to compare the salmeterol/fluticasone propionate combination (Seretidetm Diskus 50/100) 50/100microg one inhalation twice daily with fluticasone propionate (Flixotide Diskus 100) 100microg one inhalation twice daily as initial maintenance therapy for 12 weeks in adults with persistent moderate asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Mar 2022
Price :
$35
*
At a glance
- Drugs Fluticasone propionate (Primary) ; Salmeterol/fluticasone propionate
- Indications Asthma
- Focus Therapeutic Use
- Acronyms Mechanistic Study
- Sponsors GlaxoSmithKline
- 22 Mar 2012 Actual patient number 81 added as reported by ClinicalTrials.gov.
- 14 Oct 2008 Status changed from discontinued to completed.
- 15 Jan 2008 Status changed from recruiting to discontinued.